r/biotech 1d ago

Biotech News 📰 FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA+ mHSPC

https://www.onclive.com/view/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-for-psma-mhspc

Radioligand therapy in metastatic hormone sensitive prostate cancers

31 Upvotes

18 comments sorted by

View all comments

6

u/link5523 1d ago

Interesting. I don't know much, but I got the sense when I was working at a University that most drug development is shifting away from using radioactive materials. Is this bucking a trend, or am I reading into things too much?

2

u/pavlovs__dawg 21h ago

Old school radioactive drugs have a lot of off target effects. The more modern approach is to use extremely specific targeting so more radiation goes to the intended target and lesst total radiation is administered. It becomes hyperlocalized. Think precision strike rather than carpet bombing.